Implementing a National Cancer Clinical Trials System for the 21st Century - Second Workshop Summary (Paperback)

The National Clinical Trials Network (NCTN) supported by the National Cancer Institute (NCI) has played an integral role in cancer research and in establishing the standard of care for cancer patients for more than 50 years. Formerly known as the NCI Clinical Trials Cooperative Group Program, the NCTN is comprised of more than 2,100 institutions and 14,000 investigators, who enroll more than 20,000 cancer patients in clinical trials each year across the United States and internationally. Recognizing the recent transformative advances in cancer research that necessitate modernization in how cancer clinical trials are run, as well as inefficiencies and other challenges impeding the national cancer clinical trials program, the NCI asked the IOM to develop a set of recommendations to improve the federally funded cancer clinical trials system. These recommendations were published in the 2010 report, A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program. In early 2011, the NCPF and the American Society of Clinical Oncology (ASCO) held a workshop in which stakeholders discussed the changes they planned to implement in response to the IOM goals and recommendations. Two years later, on February 11-12, 2013, in Washington, DC, the NCPF and ASCO reconvened stakeholders to report on the changes they have made thus far to address the IOM recommendations. At this workshop, representatives from the NCI, the NCTN, comprehensive cancer centers, patient advocacy groups, the Food and Drug Administration (FDA), industry, and other stakeholders highlighted the progress that has been made in achieving the goals for a reinvigorated national cancer clinical trials system. Implementing a National Cancer Clinical Trials System for the 21st Century is a summary of that workshop. Table of Contents Front Matter Implementing a National Cancer Clinical Trials System for the 21st Century References Acronyms Appendix A: Workshop Statement of Task and Agenda Appendix B: Executive Summary of *A National Cancer Clinical Trials System for the 21st Century*

General

Imprint:	National Academies Press
Country of origin:	United States
Release date:	October 2013
First published:	2013
Authors:	Board on Health Care Services • National Cancer Policy Forum
Editors:	Margie Patlak • Sharyl J. Nass
Authors:	Institute of Medicine • An American Society of Clinical Oncology and Institute of Medicine Workshop
Dimensions:	229 x 152 x 0mm (L x W x T)
Format:	Paperback
Pages:	110
ISBN-13:	978-0-309-28724-1
Categories:	Books > Medicine > General issues > Medical equipment & techniques > Medical research Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN:	0-309-28724-3
Barcode:	9780309287241

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!